Delivery Order SPE2DB25D3003-SPE2DB25FPWVT
- Not listed
- The Defense Logistics Agency awarded a $1,117.20 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes management medication. This competitively awarded, firm fixed-price contract was executed on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract carries no set-aside designation and represents a discrete order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,728.65 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $36,390.38 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 25, 2025, with completion scheduled for July 28, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to the prime contractor. The pharmaceutical product will be delivered to the company's place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $9,081.90 delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Januvia 100 mg, a diabetes medication. This non-set-aside, firm fixed-price contract was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a child order under AmerisourceBergen's larger contract vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office...
- The Defense Logistics Agency awarded a $32,767.22 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award was issued on July 25, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as a child delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,641.20 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count units) under a firm fixed price contract type. The award was issued on July 21, 2025, with an ultimate completion date of July 22, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $2,140.69 firm fixed-price delivery order is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of July 2, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,867.08 firm fixed-price contract is for the supply of Januvia 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of April 29, 2025 and is not set aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,132.38 firm fixed-price delivery order is for the supply of JANUVIA 100 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of February 25, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This federal contract award, valued at $1,091.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Januvia 100 mg tablets, a medication used to treat diabetes. The contract is a firm fixed-price arrangement with a completion date of May 14, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- SPE2DB25D3003Indefinite Delivery Contract
- SPE2DB25D3003-SPE2DB25FPWVTDelivery Order
The Defense Logistics Agency awarded a $2,859.99 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a pharmaceutical treatment for type 2 diabetes. The award, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), valued at $999,999,999 through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply medications, vaccines, and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, AmerisourceBergen serves multiple federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, with the company's competitive positioning demonstrated through its selection among multiple potential contractors for the DLA's Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 7/25/25 |